Clinical Trial

RTMS for Refractory Auditory Hallucinations Based on Personalized Targets Using Magnetoencephalography

Recruiting
View on ClinicalTrials.gov →
Summary
This study is an before-after study in the same patient, which enrolled 36 psychiatric patients with refractory auditory hallucinations. The target of patient intervention relies on the results of magnetoencephalography localization. The medication and dosage remain unchanged during the intervention period. The investigators assume that the intervention targets for each auditory hallucination patient are individualized.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-26; most recent amendment 2025-02-12.
Status change: Not Yet Recruiting → Recruiting 2025-02-12
Trial Details
NCT Number NCT06802939
Lead Sponsor Shanghai Mental Health Center
Conditions Refractory Auditory Hallucinations, Schizophrenia
Enrollment 36 participants
Start Date 2025-02-05
Primary Completion 2026-12-10 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-14